EBOLA VIRUS DISEASE OUTBREAKS AS GLOBAL DISASTERS
Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 12
Abstract
Ebola virus disease (EVD) is caused by Ebola viruses (EBOV), members of the group of hemorrhagic fevers and it is one of the most dangerous infection diseases with mortality rates up to 90%. Ebola was firstly described in 1976 and since then occurred sporadically in Central Africa. Till 2014, twenty four outbreaks were described, but the number of deaths not exceeding 300 per outbreak. As of June 20, 2017 the cumulative number, suspected, and laboratory-confirmed cases attributed to Ebola virus was 26, 969, including 11,135 deaths. Pathogenesis: Ebola Viruses do not replicate through cell division, but instead insert their own genetic sequencing into the deoxyribonucleic acid (DNA) of the host cell and subsequently hijack all cellular processes, including transcription and translation. In essence, the host cell becomes a factory of viral proteins. As new viral capsules are formed, they bud from the host cell, taking a part of the host cell‟s outer membrane, thus cloaking themselves against detection by the host‟s immune system. In some cases, the patient‟s immune system can produce enough antibodies to defeat the infection. With EVD, the virus can often reproduce so rapidly that the immune system never catches up. Transmission: The natural reservoir of EBOV is believed to be bats, particularly fruit bats, and it is primarily transmitted between humans and from animals to humans through body fluids. Clinical presentation: Symptoms of EVD include abrupt onset of fever, myalgia‟s, and headache in the early phase, followed by vomiting, diarrhea and possible progression to hemorrhagic rash, life-threatening bleeding, and multi organ failure in the later phase. Treatment: There are no approved treatments or vaccines available for EVD until today; the mainstay of therapy is supportive care. However, there are a bunch of therapeutic approaches on the track which could have the real impact on control and prevention of this global threat. High fatality, combined with the absence of treatment and vaccination options, makes Ebola virus an important public health pathogen.
Authors and Affiliations
Prof. Musarrat Sharif
Keywords
Related Articles
- EP ID EP627689
- DOI -
- Views 147
- Downloads 0
A REVIEW ON NAVJAAT SHISHU PARICHARYA
Navjaat shishu paricharya (care of a newborn) has been described both in ayurveda as well as modern texts. These are the basic steps that should be followed by medical professionals after the birth of the newborn from th...
FRACTURES AND IT’S MANAGEMENT: AYURVEDIC AND MODERN PERSPECTIVES
Bhagna is common problem of the accident now a day due to speeding, drunk driving, night driving, rain, unsafe lane changes, and animal crossing etc. which was well explained with their cause sign symptom classification...
MATERNAL MORTALITY AFTER CESAREAN SECTION IN IRAQ
The aim of this research studying the association between maternal mortality and mode of birth, although this topic remains of importance, given the changing patterns in the mode of birth with increasing cesarean section...
A REVIEW ON TRADITIONAL USES AND THEREPUTIC INDICATIONS OF ANETHUM SOWA
The word ‘Dravyaguna’ means the science dealing with properties and actions of drugs. Acharya Charaka states that action of a drug may be in accordance with its Rasa, Guna, Virya, Vipaka and Prabhava. Anethum Sowa (India...
A CRITICAL STUDY OF PANDU ROGA (ANAEMIA) W.S.R.TO YAKRUT (LIVER)
Now a days, Pandu roga (Anaemia) is found in large scale among all age group irrelevant to gender, so there is need to give much more importance to its treatment. Chronic liver diseases of any cause is frequently associa...